Skip to main content
. 2021 Apr 29;11:9313. doi: 10.1038/s41598-021-88619-4

Table 2.

Statistical significance of variables used in disease state definition (i.e., clinical assessments) and action (medications).

Time Variables Coef p-value
t1 (Variables used in disease state definition)
Hoehn and Yahr 0.8967 0
Age 0.0864 0
Total MoCA − 0.0534 0.01
Total UPDRS III scores 0.7816 0
% change of total UPDRS scores − 0.0246 0
Subtype AR (vs. mixed type) 1.5576 0
Subtype TD (vs. mixed type) 0.6056 0.213
Levodopa 5.5486 0
Dopamine agonist 4.5439 0
Other medicine 2.2017 0
Levodopa + Other medicine 5.942 0
Levodopa + Dopamine agonist 5.5351 0
Dopamine agonist + Other medicine 3.8986 0
Levodopa + Dopamine agonist + Other medicine 6.1054 0
t2 (Variables used in actions)
Levodopa − 6.9801 0
Dopamine agonist − 5.0293 0
Other medicine − 0.825 0.094
Levodopa + other medicine − 6.9232 0
Levodopa + Dopamine agonist − 7.2501 0
Dopamine agonist + other medicine − 5.1182 0
Levodopa + Dopamine agonist + other medicine − 8.5083 0
(Outcome) total UPDRS III scores

We fitted prediction model as total UPDRS scores at t2 (penalty) ~ variables at t1 (used in disease state) + variables at t2 (actions) using multivariate regression (i.e., generalized least square) and selected variables that are statistically significant on total UPDRS scores on the next timestep (t2). Note that the % change of total UPDRS scores are 100% × (Total UPDRS scores at t1 − Total UPDRS scores at t0)/Total UPDRS scores at t0. AR = Akinetic-rigid, TD = tremor-dominant.